supported by FONDECYT-11140738 (G.M.).;Michael J. Fox Foundation for Parkinson Research, Ring Initiative ACT1109;FONDEF D11I1007 (C.H.). We also thank, FONDECYT-1140549;Millennium Institute P09-015-F, COPEC-UC, and Frick Foundation (C.H.). V.C. is supported by CONICYT fellowship
Parkinson’s disease(PD)is the second most common neurodegenerative disease affecting 1%of the population over 60 years of age.The progressive degeneration of dopaminergic neurons at the substantia nigra pars compa...